Phosphate buffer-stabilized 0.1% chlorine dioxide oral rinse for managing medication-related osteonecrosis of the jaw. [electronic resource]
- American journal of dentistry 12 2017
- 350-352 p. digital
Publication Type: Journal Article; Review
0894-8275
Bisphosphonate-Associated Osteonecrosis of the Jaw--drug therapy Chlorine Compounds--therapeutic use Dental Disinfectants--therapeutic use Humans Osteonecrosis Oxides--therapeutic use Phosphates